Prevention of Tuberculosis in Prisons

NCT03028129 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

467

Enrollment

OTHER

Sponsor class

Stopped Interim analysis showed efficacy less than 2.5%.

Conditions

Tuberculosis, Pulmonary
Antibiotic Prophylaxis

Interventions

DRUG: Isoniazid 900 milligrams
DRUG: Placebo

Sponsor

Federal University of Mato Grosso

Collaborators

[object Object]